Bi-allelic MYMX variants cause a syndromic congenital myopathy with recognizable facial palsy, growth restriction, and dysmorphism

Myogenic fusion, primarily regulated by the Myomaker and Myomixer proteins, is essential for skeletal muscle development, yet its mechanisms remain poorly understood. This study presents the clinical and molecular details of the third and fourth reported patients with biallelic variants in MYMX, the gene that encodes Myomixer. We identified a homozygous truncating variant [c.107 T > A (p.Leu36Ter)] and a homozygous stop-codon loss variant [c.255 A > G (p.Ter85TrpextTer41)] in MYMX, both associated with a complex neuromuscular syndrome characterized by generalized hypotonia, congenital myopathy, facial nerve palsy, growth restriction and facial dysmorphism. Additional variable features include hearing loss (confirmed in one patient, suspected in the other), scoliosis, joint contractures, cleft palate, hypoglossia, potentially contributing to Pierre Robin sequence, and abnormalities on neuroimaging studies including cerebellar atrophy and Chiari 1 deformity. Comparative analysis of patients with pathogenic variants in MYMK and MYMX, including our cases, reveals largely overlapping phenotypes, underscoring their synergistic role in myofiber formation and implicating their involvement in the etiology of neuromuscular conditions.

Authors

Institutions

Publication Details

Journal
European Journal of Human Genetics
Published
2024-12-12
DOI
https://doi.org/10.1038/s41431-024-01759-9
Citations
2
Primary Topic
Neurogenetic and Muscular Disorders Research
Type
article
Field-Weighted Citation Impact
0.88

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bi-allelic MYMX variants cause a syndromic congenital myopathy with recognizable facial palsy, growth restriction, and dysmorphism

Shazia Maqbool, Gabriela E. Oprea, Fatima Rahman, Stéphanie Efthymiou et al.
2 citations
European Journal of Human Genetics
Neurogenetic and Muscular Disorders Research
0.88
article

Bi-allelic MYMX variants cause a syndromic congenital myopathy with recognizable facial palsy, growth restriction, and dysmorphism

Shazia Maqbool, Gabriela E. Oprea, Fatima Rahman, Stéphanie Efthymiou, Barbara Vona, Cesar Alves, Huma Arshad Cheema, Domizia Pasquetti, Thomas Smol, Abolfazl Rad, Luisa Marsili, Henry Houlden, Reza Maroofian, Muhammad Nadeem Anjum
article en
2 citations

Abstract

Myogenic fusion, primarily regulated by the Myomaker and Myomixer proteins, is essential for skeletal muscle development, yet its mechanisms remain poorly understood. This study presents the clinical and molecular details of the third and fourth reported patients with biallelic variants in MYMX, the gene that encodes Myomixer. We identified a homozygous truncating variant [c.107 T > A (p.Leu36Ter)] and a homozygous stop-codon loss variant [c.255 A > G (p.Ter85TrpextTer41)] in MYMX, both associated with a complex neuromuscular syndrome characterized by generalized hypotonia, congenital myopathy, facial nerve palsy, growth restriction and facial dysmorphism. Additional variable features include hearing loss (confirmed in one patient, suspected in the other), scoliosis, joint contractures, cleft palate, hypoglossia, potentially contributing to Pierre Robin sequence, and abnormalities on neuroimaging studies including cerebellar atrophy and Chiari 1 deformity. Comparative analysis of patients with pathogenic variants in MYMK and MYMX, including our cases, reveals largely overlapping phenotypes, underscoring their synergistic role in myofiber formation and implicating their involvement in the etiology of neuromuscular conditions.

European Journal of Human GeneticsVol. 33(4)
Università Cattolica del Sacro Cuore (IT), Boston Children's Hospital (US), Harvard University (US), Utrecht University (NL), Université de Lille (FR), University of Health Sciences Lahore (PK), University Medical Center Utrecht (NL), Centre Hospitalier Universitaire de Lille (FR), Universitätsmedizin Göttingen (DE), MRC Prion Unit (GB), CS Diagnostics (DE), National Hospital for Neurology and Neurosurgery (GB), University College London (GB), University of Göttingen (DE)
Michael J. Fox Foundation for Parkinson's Research, Wellcome Trust, Multiple System Atrophy Coalition, National Institute for Health and Care Research, University College London, Rosetrees Trust, Deutsche Forschungsgemeinschaft, National Institutes of Health, Medical Research Council
Good health and well-being
Openalex Percentile: Top 22%
Neurogenetic and Muscular Disorders Research
0.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.